Researchers argue patients will benefit from breaking the ties between physicians and pharmaceutical companies. While physicians say drug companies provide needed product information, the researchers wrote in the Journal of the American Board of Family Medicine that there are plenty of impartial academic sources for data, and they argue doctors' offices often are stocked with new, expensive medications that may be no better than cheaper generics.

Related Summaries